Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhNGF for Post-Surgical Dry Eye
NCT03035864Phase 2Completed
- Sponsor
- Dompé
- Start
- Jan 2017
- Primary completion
- Sep 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of cenegermin in dry eye syndrome (DED), sponsored by Dompé. Started Jan 2017; status: completed.
02
Drugs
cenegermin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03035864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03035864.